Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women.
作者信息
Liu S, Semenciw R, Mao Y
出版信息
CMAJ. 2001 Apr 17;164(8):1151-2.
Abstract
摘要
相似文献
1
Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women.
CMAJ. 2001 Apr 17;164(8):1151-2.
2
[Cervical cancer in the young woman].
J Gynecol Obstet Biol Reprod (Paris). 1993;22(7):743-7.
3
Support for down-staging of pregnancy-associated cervical cancer.
Acta Obstet Gynecol Scand. 2015 Jun;94(6):654-9. doi: 10.1111/aogs.12645. Epub 2015 Apr 29.
4
Screening and adenocarcinoma of the cervix.
Int J Cancer. 2009 Aug 1;125(3):525-9. doi: 10.1002/ijc.24410.
5
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas.
Int J Cancer. 1998 Feb 9;75(4):536-45. doi: 10.1002/(sici)1097-0215(19980209)75:4<536::aid-ijc8>3.0.co;2-u.
6
Ovarian metastasis in stage IB and II cervical adenocarcinoma.
Gynecol Oncol. 1999 Aug;74(2):255-8. doi: 10.1006/gyno.1999.5442.
7
Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Cytopathology. 2012 Feb;23(1):23-9. doi: 10.1111/j.1365-2303.2010.00816.x. Epub 2010 Oct 21.
8
Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
Gynecol Oncol. 2007 Dec;107(3):458-63. doi: 10.1016/j.ygyno.2007.07.080. Epub 2007 Sep 12.
9
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England.
Lancet. 2001 May 12;357(9267):1490-3. doi: 10.1016/S0140-6736(00)04646-8.
10
Evaluation of histologically confirmed carcinoma of the cervix in Nnewi Nigeria: A five year review.
Niger J Med. 2016 Jul-Sep;25(3):210-4.
引用本文的文献
1
Effect of metabolic syndrome and its components on the risk and prognosis of cervical cancer: A literature review.
Gynecol Oncol Rep. 2024 Jun 22;54:101438. doi: 10.1016/j.gore.2024.101438. eCollection 2024 Aug.
2
P16/Ki67 Dual Staining in Glandular Cell Abnormalities of the Uterine Cervix.
Cancers (Basel). 2024 Apr 23;16(9):1621. doi: 10.3390/cancers16091621.
3
P16 expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway.
Sci Rep. 2021 Sep 14;11(1):18236. doi: 10.1038/s41598-021-97703-8.
4
Prognostic Model for Predicting Overall and Cancer-Specific Survival Among Patients With Cervical Squamous Cell Carcinoma: A SEER Based Study.
Front Oncol. 2021 Jul 14;11:651975. doi: 10.3389/fonc.2021.651975. eCollection 2021.
5
Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.
BMC Womens Health. 2021 Mar 18;21(1):110. doi: 10.1186/s12905-021-01242-3.
6
Safety and Prognostic Impacts of Ovarian Preservation during Radical Hysterectomy for Early-Stage Adenocarcinoma and Adenosquamous Cervical Cancer.
Biomed Res Int. 2020 Nov 12;2020:5791381. doi: 10.1155/2020/5791381. eCollection 2020.
7
Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):627-641. doi: 10.21873/cgp.20219.
8
αGlcNAc and its catalyst α4GnT are diagnostic and prognostic markers in uterine cervical tumor, gastric type.
Sci Rep. 2019 Sep 10;9(1):13043. doi: 10.1038/s41598-019-49376-7.
9
Clinicopathological and biological analysis of mutation and amplification in cervical carcinomas.
Exp Ther Med. 2019 Sep;18(3):2278-2284. doi: 10.3892/etm.2019.7771. Epub 2019 Jul 12.
10
Cervical cancer in women aged 25 years or younger: a retrospective study.
Cancer Manag Res. 2019 Mar 6;11:2051-2058. doi: 10.2147/CMAR.S195098. eCollection 2019.
本文引用的文献
1
Trends in cancer of the cervix uteri in Sweden following cytological screening.
Br J Cancer. 1999 Sep;81(1):159-66. doi: 10.1038/sj.bjc.6690666.
2
Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.
BMJ. 1999 Apr 3;318(7188):904-8. doi: 10.1136/bmj.318.7188.904.
3
The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon.
Int J Epidemiol. 1996 Apr;25(2):252-8. doi: 10.1093/ije/25.2.252.
4
Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem.
Epidemiol Rev. 1993;15(2):486-98. doi: 10.1093/oxfordjournals.epirev.a036131.
5
Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.
Br J Cancer. 1995 Apr;71(4):894-7. doi: 10.1038/bjc.1995.172.
6
Increasing mortality from cancer of the cervix in young Australian women.
Med J Aust. 1981 May 2;1(9):460-2. doi: 10.5694/j.1326-5377.1981.tb135734.x.
7
Evaluation of screening for cervical cancer in Sweden: trends in incidence and mortality 1958-1980.
Int J Epidemiol. 1985 Dec;14(4):521-7. doi: 10.1093/ije/14.4.521.
8
Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.
Br Med J (Clin Res Ed). 1988 Apr 2;296(6627):975-8. doi: 10.1136/bmj.296.6627.975.
9
Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization.
Gynecol Oncol. 1989 Dec;35(3):345-8. doi: 10.1016/0090-8258(89)90076-0.
10
Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix.
Int J Cancer. 1976 May 15;17(5):602-12. doi: 10.1002/ijc.2910170508.
Zotero 插件